Autopsy report · NCT02341300

Use of Cast Iron Pots to Improve Maternal Anemia

“Original investigator has left the institution.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 6 years before it started.
• Ran for about 0 months before it stopped.
• 34 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Weill Medical College of Cornell University

Sponsor type

University, hospital or other

Conditions

Iron-deficiency Anemia

Interventions

Cast Iron Pot; Alumnium Pot

Participants

34

Sites

1

Countries

United States

Trials that died the same way

• Intralesional Tetracycline Injection in the Treatment of Chalazia
  “Investigator left the institution” (94% match in meaning)
• Impact of Statins on Cytokine Expression in Pneumonia
  “Investigator left institution.” (91% match in meaning)
• Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
  “Original Principal Investigator left the institution.” (90% match in meaning)
• Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
  “Original investigator left this institution, replacement investigator retired.” (90% match in meaning)
• Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma
  “The original principal Investigator left the institution.” (90% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.